T1	Condition 560 575	type 2 diabetes
T2	Condition-Name 560 575	type 2 diabetes
E1	Condition:T1 Name:T2 Temporality:E7
T5	Life-Stage-And-Gender 454 460	female
A1	Life-Stage-And-Gender-Type T5 female
T6	Life-Stage-And-Gender 446 450	Male
A2	Life-Stage-And-Gender-Type T6 male
T7	Eq-Operator 466 487	greater than or equal
A3	Eq-Operator-Value T7 GTEQ
T8	Eq-Operator 673 691	less than or equal
A4	Eq-Operator-Value T8 LTEQ
T9	Eq-Operator 1037 1043	within
A5	Eq-Operator-Value T9 LTEQ
T10	Eq-Temporal-Unit 494 499	years
A6	Eq-Temporal-Unit-Value T10 year
T11	Eq-Temporal-Unit 588 593	weeks
A7	Eq-Temporal-Unit-Value T11 week
T12	Eq-Temporal-Unit 698 703	weeks
A8	Eq-Temporal-Unit-Value T12 week
T13	Eq-Temporal-Unit 1047 1051	days
A9	Eq-Temporal-Unit-Value T13 day
T14	Age 462 465	age
E4	Age:T14 Eq-Comparison:E3
T15	Eq-Value 491 493	18
T17	Eq-Value 585 587	12
T18	Eq-Value 695 697	12
T19	Eq-Value 1044 1046	90
T20	Eq-Comparison 1037 1051	within 90 days
E5	Eq-Comparison:T20 Operator:T9 Temporal-Unit:T13 Value:T19
T21	Eq-Comparison 774 782	Previous
E6	Eq-Comparison:T21 Temporal-Period:T22
T22	Eq-Temporal-Period 774 782	Previous
A10	Eq-Temporal-Period-Value T22 past
T23	Eq-Comparison 576 593	at least 12 weeks
E7	Eq-Comparison:T23 Operator:T24 Value:T17 Temporal-Unit:T11
T25	Temporal-Connection 704 712	prior to
E8	Temporal-Connection:T25 Arg:E14 Arg2:E15
T27	Temporal-Connection 1052 1060	prior to
E9	Temporal-Connection:T27 Arg:E5 Arg2:E25
T3	Or 451 453	or
E2	Or:T3 Arg:T6 Arg2:T5
T4	Eq-Comparison 466 499	greater than or equal to 18 years
E3	Eq-Comparison:T4 Operator:T7 Temporal-Unit:T10 Value:T15
T16	Temporal-Connection 594 602	prior to
E10	Temporal-Connection:T16 Arg:E7 Arg2:E11
A11	Temporal-Connection-Type-Value E10 before
T24	Eq-Operator 576 584	at least
A14	Eq-Operator-Value T24 GTEQ
T29	Study 603 612	inclusion
E11	Study:T29 
T30	Observation 643 658	haemoglobin A1c
E12	Observation:T30 Name:T31
T31	Observation-Name 643 658	haemoglobin A1c
A15	Observation-Type-Value T31 lab
T32	Observation 660 665	HbA1c
E13	Observation:T32 Name:T33 Temporality:E14
T33	Observation-Name 660 665	HbA1c
A16	Observation-Type-Value T33 lab
R1	Abbrev-Of Arg1:E13 Arg2:E12	
T34	Eq-Comparison 673 703	less than or equal to 12 weeks
E14	Eq-Comparison:T34 Operator:T8 Temporal-Unit:T12 Value:T18
A17	Temporal-Connection-Type-Value E8 before
T26	Eq-Comparison 713 723	initiation
E15	Eq-Comparison:T26 Temporal-Recency:T35
T35	Eq-Temporal-Recency 713 723	initiation
A12	Eq-Temporal-Recency-Value T35 first-time
T36	Procedure 739 748	treatment
E16	Procedure:T36 Temporality:E15
T37	Drug 727 738	semaglutide
E17	Drug:T37 Name:T38
T38	Drug-Name 727 738	semaglutide
R2	Using Arg1:E16 Arg2:E17	
T39	Study 805 810	study
E18	Study:T39 Temporality:E6
T40	Condition 889 906	Mental incapacity
E19	Condition:T40 Name:T41
T41	Condition-Name 889 906	Mental incapacity
T42	Condition 925 942	language barriers
E20	Condition:T42 Name:T43
T43	Condition-Name 925 942	language barriers
T44	Or 922 924	or
E21	Or:T44 Arg:E19 Arg2:E20
T45	Procedure 997 1006	Treatment
E22	Procedure:T45 Temporality:E5
T46	Drug 1032 1036	drug
E23	Drug:T46 
T47	Study 1016 1031	investigational
E24	Study:T47 Study-Of:E23
R3	Using Arg1:E22 Arg2:E23	
A13	Temporal-Connection-Type-Value E9 before
T28	Study 1080 1085	study
E25	Study:T28 
T48	Drug 1111 1122	semaglutide
E26	Drug:T48 Name:T49
T49	Drug-Name 1111 1122	semaglutide
T50	Condition 1091 1107	Hypersensitivity
E27	Condition:T50 Name:T51
T51	Condition-Name 1091 1107	Hypersensitivity
R4	Caused-By Arg1:E27 Arg2:E26	
